UiPath(PATH)2025-05-29 20:16Financial Performance - Revenue for Q1 fiscal 2026 was $357 million, representing a 6% increase year-over-year[5] - Annualized Renewal Run-rate (ARR) reached $1.693 billion, up 12% year-over-year, with net new ARR of $27 million[5][2] - Total revenue for the three months ended April 30, 2025, was $356.624 million, a 6.4% increase from $335.112 million in the same period of 2024[25] - Subscription services revenue increased to $217.303 million, up 17.4% from $185.131 million year-over-year[25] - Net loss for the quarter was $(22.555) million, or $(0.04) per share, compared to a net loss of $(28.736) million, or $(0.05) per share, in the prior year[25] - GAAP net loss for the three months ended April 30, 2025, was $22,555,000, an improvement from a loss of $28,736,000 in the same period of 2024[37] - Non-GAAP net income for the same period was $60,174,000, compared to $73,218,000 in 2024, reflecting a decrease of approximately 17.8%[37] Cash Flow and Margins - Non-GAAP adjusted free cash flow was $117 million, while cash flow from operations was $119 million[5] - GAAP gross margin stood at 82%, and non-GAAP gross margin was 84%[5] - Non-GAAP operating income for the quarter was $69.616 million, with a non-GAAP operating margin of 20%, up from 15% in the previous year[34] - GAAP net cash provided by operating activities increased to $119,002,000 in Q1 2025 from $100,037,000 in Q1 2024, representing a growth of 18.9%[40] - Non-GAAP adjusted free cash flow for the three months ended April 30, 2025, was $117,067,000, up from $101,277,000 in 2024, indicating an increase of 15.6%[40] Stock and Shareholder Actions - The company repurchased $227.525 million of Class A common stock during the quarter[29] - The weighted average common shares outstanding, basic and diluted, decreased to 548,451 in Q1 2025 from 569,925 in Q1 2024[37] - Stock-based compensation expense decreased to $76,361,000 in Q1 2025 from $88,727,000 in Q1 2024, a reduction of approximately 13.9%[37] - The company reported a charitable donation of Class A common stock valued at $4,187,000 in Q1 2025, down from $6,564,000 in Q1 2024[37] Future Projections - For Q2 fiscal 2026, revenue is expected to be in the range of $345 million to $350 million, with ARR projected between $1.715 billion and $1.720 billion[6] Product Development and Partnerships - The company launched its next-generation UiPath Platform for agentic automation, enhancing its product offerings[8] - UiPath Test Cloud was introduced to improve software testing efficiency using advanced AI[8] - The company announced a partnership with Google Cloud to develop a generative AI-based Medical Record Summarization agent[9] Market Recognition - UiPath achieved a dollar-based net retention rate of 108%[5] - The company was recognized as a Leader in the IDC MarketScape for Worldwide Business Automation Platforms 2025[8] Assets and Liabilities - Cash and cash equivalents decreased to $700.641 million from $879.196 million at the beginning of the year[27] - Total current assets decreased to $2.110 billion from $2.339 billion at the end of January 2025[27] - Total liabilities decreased to $945.981 million from $1.020 billion at the end of January 2025[27] Operating Loss - Operating loss improved to $(16.412) million compared to $(49.465) million in the same quarter of 2024[34] Restructuring Costs - The company incurred restructuring costs of $3,011,000 in Q1 2025, while there were no such costs reported in Q1 2024[37]